Fluorescent In Situ Hybridisation (FISH) testing for Multiple Myeloma
A targeted FISH panel to exclude common abnormalities with prognostic significance in Multiple Myeloma
Multiple Myeloma FISH panel
For diagnosis, classification and prognosis in haem-oncology
CKS1B/CDKN2C (1PQ), IGH/CCND1(MYEOV), IGH, Del(13q) (RB1/DLEU1/LAMP1), TP53
Extended panel: IGH/FGFR3, IGH/MAF, IGH/MAFB, IGH/CCND3, IGH/MYC
FISH
2 – 14 days
77314 – criteria applies
If not MBS eligible, please contact 1800 822 999 for pricing details
Standard pathology request form
Bone marrow aspirate in lithium heparin tube
Bone marrow
Doctor collect. No additional sample required. Test is performed with chromosome analysis.